| Product Name | MF | CAS | Details |
|---|
| 1-(3-Amino-4-bromophenyl)-3,3-dimethylpyrrolidine-2,5-dione | C12H13BrN2O2 | 1506034-25-8 | Details |
| 4-(Bromomethyl)-1,3-dioxane | C5H9BrO2 | 31100-39-7 | Details |
| 2-Chloro-N-(2-sulfamoylphenyl)acetamide | C8H9ClN2O3S | 89981-37-3 | Details |
| 7-Amino-2-{[(tert-butoxy)carbonyl]amino}heptanoic acid | C12H24N2O4 | 1822533-14-1 | Details |
| 2-Bromo-6-chloro-4-fluorobenzene-1-sulfonyl chloride | C6H2BrCl2FO2S | 1208076-43-0 | Details |
| [(3-Fluorophenyl)(1-methyl-1H-pyrazol-4-yl)methyl](methyl)amine | C12H14FN3 | 1153244-33-7 | Details |
| SFTPA2 antibody | Details |
| (R)-N-(2,3-Dihydro-1H-indenyl)adenosine | C19H21N5O4 | 96392-15-3 | Details |
| D-Glucose - anhydrous | C6H12O6 | 50-99-7 | Details |
| N-(3-Hydroxyphenyl)-6-methylpyridine-2-carboxamide | C13H12N2O2 | 1038243-81-0 | Details |
| 6-Isopentenyloxyisobergapten | C17H16O5 | 24099-29-4 | Details |
| 1-(2,4-Dihydroxyphenyl)-2-(4-methoxyphenyl)ethanone | C15H14O4 | 487-49-0 | Details |
| PI3K P85 antibody | Details |
| Resveratrol triacetate | C20H18O6 | 42206-94-0 | Details |
| Betamethasone 21-acetate | C24H31FO6 | 987-24-6 | Details |
| 3-[(2-Methylprop-2-en-1-yl)oxy]benzene-1-sulfonyl chloride | C10H11ClO3S | 1339767-38-2 | Details |
| PIF1 antibody | Details |
| ITLN2 antibody | Details |
| 3’-Deoxy-5-methoxyuridine | C10H14N2O6 | 2095417-49-3 | Details |
| TUT1 Blocking Peptide | Details |
| 2-(2-Ethylphenyl)acetonitrile | C10H11N | 74533-20-3 | Details |
| NAT9 antibody | Details |
| 1-(2,6-Difluorophenyl)cyclopentane-1-carbonitrile | C12H11F2N | 1260877-15-3 | Details |
| (1R)-1-(5-Bromo-2,3-dihydro-1-benzofuran-7-yl)ethan-1-ol | C10H11BrO2 | 1568011-77-7 | Details |
| 2-[2-(1-Methyl-1H-indol-3-yl)ethyl]-2,3-dihydro-1H-isoindole-1,3-dione | C19H16N2O2 | 70369-20-9 | Details |
| Cefdinir impurity E | C14H13N5O5S2 | 946573-41-7 | Details |
| Human IL1b ELISA kit | Details |
| 4-Chloro-9H-pyrido[2,3-b]indole | C11H7ClN2 | 25208-32-6 | Details |
| Regaloside A | C18H24O10 | 114420-66-5 | Details |
| Methyl cyclopentylphenylglycolate | C14H18O3 | 19833-96-6 | Details |
| Methyl 4-methoxy-1-benzothiophene-3-carboxylate | 2114800-81-4 | Details |
| 5-Bromo-3-(difluoromethyl)-2-methoxypyridine | C7H6BrF2NO | 1254123-51-7 | Details |
| 2-(Cyclohexylmethylidene)propanedinitrile | C10H12N2 | 73776-46-2 | Details |
| 5-Bromo-6-chloro-3-indoxyl nonanoate | C17H21BrClNO2 | 682802-80-8 | Details |
| 4-Methyl-2-phenyl-2-oxazoline-5-one | C10H9NO2 | 13302-43-7 | Details |
| N-(Propan-2-yl)pyrrolidine-3-sulfonamide | C7H16N2O2S | 1423034-00-7 | Details |
| N,N,1-Trimethyl-1H-1,3-benzodiazol-4-amine | C10H13N3 | 1521834-83-2 | Details |
| 2-(3-Methylpyridin-2-yl)ethanamine | C8H12N2 | 851670-19-4 | Details |
| 1-(2-Methoxyphenyl)-1H-pyrazole-5-carboxylic acid | C11H10N2O3 | 1783977-51-4 | Details |
| Fmoc-D-Pro-OH | C20H19NO4 | 101555-62-8 | Details |
| (Des-Gly10,D-Tyr5,D-Ser(tBu)6,Pro-NHEt 9)-LHRH acetate salt | C60H86N16O13 | 1426174-33-5 | Details |
| (4-Chlorophenyl)(thiophen-3-yl)methanone | C11H7ClOS | 896618-56-7 | Details |
| Ethyl 2-undecynoate | C13H22O2 | 10519-17-2 | Details |
| 4-Chlorobenzoyl chloride | C7H4Cl2O | 122-01-0 | Details |
| FBXO11 Blocking Peptide | Details |
| 2,3-Diaminobenzonitrile | C7H7N3 | 73629-43-3 | Details |
| Mac glucuronide linker-1 | C42H47N3O17S | 2222981-71-5 | Details |
| 3-(2-Chlorophenyl)-4-methyl-4H-1,2,4-triazole | C9H8ClN3 | 168968-41-0 | Details |
| H-QIFGDYK-OH | Details |
| 2-Fluoro-4-phenylbenzaldehyde | C13H9FO | 183436-80-8 | Details |
| SPINT1 antibody | Details |
| 2-(3,3-Difluorocyclopentyl)acetic acid | C7H10F2O2 | 1260837-43-1 | Details |
| Ethyl 2-O-benzyl-b-D-thioglucopyranoside | Details |
| 5-Amino-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid tert-butyl ester | C15H22N2O2 | 811841-95-9 | Details |
| 2-(1-Phenyl-3-(piperidin-1-yl)propyl)pyridine | C19H24N2 | 102008-18-4 | Details |
| 5-(4,5-Dimethyl-1H-imidazol-1-yl)pentanenitrile | C10H15N3 | 1251393-72-2 | Details |
| 2-Chloro-6-(3-chloro-4-fluorophenoxy)benzoic acid | C13H7Cl2FO3 | 1485267-27-3 | Details |
| Lappaol B | C31H34O9 | 62359-60-8 | Details |
| CREBBP antibody | Details |
| 2-(Piperidin-4-ylsulfanyl)pyridine dihydrochloride | C10H16Cl2N2S | 99202-39-8 | Details |
| (Hydroxypropyl)methyl cellulose - USP, substitution type 2910 (viscosity 3000-5600mpa.s) | C3H7O* | 9004-65-3 | Details |
| 6-(4-Fluorophenyl)-2-methylpyridine-3-carboxylic acid | C13H10FNO2 | 582325-06-2 | Details |
| Fluor 647 NHS ester tripotassium | C40H50KN3O16S4 | 1453856-34-2 | Details |
| Monosialyl, monofucosyllacto-N-neohexaose | Details |
| 11-Mercaptoundecanoic acid | C11H22O2S | 71310-21-9 | Details |
| [2-(1H-Pyrazol-1-yl)pyridin-3-yl]methanol | C9H9N3O | 1247904-47-7 | Details |
| TAMRA azide, 5-isomer | C28H28N6O4 | 825651-66-9 | Details |
| N-Butyl-1H-1,3-benzodiazol-2-amine | C11H15N3 | 51314-51-3 | Details |
| 4-tert-Butyl-2,6-dimethylbenzoic acid | C13H18O2 | 58537-98-7 | Details |
| 17-Oxapentacyclo[6.6.5.0-2,7-.0-9,14-.0-15,19-]nonadeca-2,4,6,9,11,13-hexaene-16,18-dione | C18H12O3 | 5443-16-3 | Details |
| (2-Propylcyclopentyl)methanamine hydrochloride | C9H20ClN | 1864015-30-4 | Details |
| 2-(4-Bromophenoxy)-3-methylbutanoic acid | C11H13BrO3 | 63403-28-1 | Details |
| 2-Chloro-1-(4-methyl-1H-indol-3-yl)ethan-1-one | C11H10ClNO | 115027-17-3 | Details |
| 1-[(4,5-Dimethoxy-2-methylphenyl)methyl]piperazine | C14H22N2O2 | 523980-89-4 | Details |
| PLEKHA1 Blocking Peptide | Details |
| 1-(3,4-Dimethoxyphenyl)ethan-1-amine hydrochloride | C10H16ClNO2 | 91252-27-6 | Details |
| 4-Methyl-6-(methylsulfanyl)-2-(propan-2-yl)pyrimidine-5-carboxylic acid | C10H14N2O2S | 926199-22-6 | Details |
| 3-(2,4-Difluorophenyl)-1-methyl-1H-pyrazole-4-carboxylic acid | C11H8F2N2O2 | 1152508-27-4 | Details |
| 4-{[1-(2,5-Dichlorophenyl)ethyl]amino}-3-methylbenzoic acid | C16H15Cl2NO2 | 1157325-96-6 | Details |
| rac-(1R,4S)-6-Oxobicyclo[2.2.1]heptane-2-carboxylic acid | C8H10O3 | 1909301-17-2 | Details |
| RHOG Blocking Peptide | Details |
| 2-Bromo-1,3-oxazole-4-carbaldehyde | C4H2BrNO2 | 1092351-90-0 | Details |
| N-Benzylpyrrolidine-3-carboxamide hydrochloride | C12H17ClN2O | 1830377-54-2 | Details |
| 2-(Hydroxymethyl)-N,N-dimethyl-1H-1,3-benzodiazole-5-sulfonamide | C10H13N3O3S | 926273-24-7 | Details |
| Benzyl 3-sulfamoylpropanoate | C10H13NO4S | 1394738-31-8 | Details |
| Taxusin | C28H40O8 | 19605-80-2 | Details |
| N-Benzyl-4,6-dimethyl-1,3-benzothiazol-2-amine | C16H16N2S | 748777-75-5 | Details |
| 3-Bromo-2-ethynylpyridine | C7H4BrN | 96439-99-5 | Details |
| 5-Chloro-1-(4-fluorophenyl)-3-methyl-1H-pyrazole-4-carboxylic acid | C11H8ClFN2O2 | 926190-52-5 | Details |
| 2-Amino-3-chlorophenol hydrochloride | C6H7Cl2NO | 858013-95-3 | Details |
| 4-{[(tert-Butoxy)carbonyl]amino}-2-oxabicyclo[2.2.1]heptane-1-carboxylic acid | C12H19NO5 | 2411196-08-0 | Details |
| Syphilis (RPR) Positive Human Serum | Details |
| 3,4-Dehydro-L-proline methyl ester hydrochloride | C6H10ClNO2 | 51827-12-4 | Details |
| H-ELVALLVR-OH | Details |
| (S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide | C16H21FN4O3 | 154590-66-6 | Details |
| {8-Methyl-5-oxaspiro[3.5]nonan-8-yl}methanamine | C10H19NO | 2060005-87-8 | Details |
| Trans-(2-fluorocyclopentyl)methanamine hydrochloride | C6H13ClFN | 1951441-85-2 | Details |
| tert-Butyl (1S,4S,5R)-5-amino-2-azabicyclo[2.1.1]hexane-2-carboxylate | C10H18N2O2 | 1027177-72-5 | Details |
| 3-Amino-2-(2-chlorophenyl)-1,1,1-trifluoropropan-2-ol hydrochloride | C9H10Cl2F3NO | 1221726-05-1 | Details |
| 2-(Butan-2-ylsulfanyl)-5-nitrobenzoic acid | C11H13NO4S | 1019562-00-5 | Details |
| Product Total： Product Page： | ||||
| 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 | ||||